| Kevin Harm, APRN | |
|
3775 45th Ave, Columbus, NE 68601-4427 | |
| (402) 564-7200 | |
| (402) 564-7210 |
| Full Name | Kevin Harm |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner - Family |
| Location | 3775 45th Ave, Columbus, Nebraska |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922025790 | NPI | - | NPPES |
| 10026109600 | Medicaid | NE | |
| 10025279800 | Medicaid | NE | |
| 37416 | Other | NE | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | 110386 (Nebraska) | Secondary |
| 363LF0000X | Nurse Practitioner - Family | 110386 (Nebraska) | Primary |
| Entity Name | Good Neighbor Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740491786 PECOS PAC ID: 0840100392 Enrollment ID: O20040327000235 |
News Archive
A study led by Ludwig Chicago Co-director Ralph Weichselbaum and Yang-Xin Fu of the University of Texas Southwestern Medical Center has shown how bacteria in the gut can dull the efficacy of radiotherapy, a treatment received by about half of all cancer patients.
Bernard Arulanandam, UTSA Jane and Roland Blumberg Professor in Biology and Assistant Vice President for Research Support, has been named a fellow of the American Association for the Advancement of Science. Arulanandam was elected by his peers for the honor, recognizing his scientific and socially distinguished efforts to advance science and its applications.
Researchers at McGill University have discovered that a key regulator of energy metabolism in cancer cells known as the AMP-activated protein kinase (AMPK) may play a crucial role in restricting cancer cell growth. AMPK acts as a "fuel gauge" in cells; AMPK is turned on when it senses changes in energy levels, and helps to change metabolism when energy levels are low, such as during exercise or when fasting.
The Pharmaceutical Research and Manufacturers of America (PhRMA) issued the following statement today on passage of comprehensive health care reform and accompanying reconciliation legislation in the U.S. House of Representatives:
Protein Design Labs, Inc. and privately held Orphan Therapeutics, LLC today reported that the U.S. Food and Drug Administration (FDA) has granted Fast Track status to the development of terlipressin for the treatment of patients with type 1 hepatorenal syndrome (HRS).
› Verified 6 days ago
| Entity Name | Good Neighbor Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902287261 PECOS PAC ID: 0840100392 Enrollment ID: O20150624001057 |
News Archive
A study led by Ludwig Chicago Co-director Ralph Weichselbaum and Yang-Xin Fu of the University of Texas Southwestern Medical Center has shown how bacteria in the gut can dull the efficacy of radiotherapy, a treatment received by about half of all cancer patients.
Bernard Arulanandam, UTSA Jane and Roland Blumberg Professor in Biology and Assistant Vice President for Research Support, has been named a fellow of the American Association for the Advancement of Science. Arulanandam was elected by his peers for the honor, recognizing his scientific and socially distinguished efforts to advance science and its applications.
Researchers at McGill University have discovered that a key regulator of energy metabolism in cancer cells known as the AMP-activated protein kinase (AMPK) may play a crucial role in restricting cancer cell growth. AMPK acts as a "fuel gauge" in cells; AMPK is turned on when it senses changes in energy levels, and helps to change metabolism when energy levels are low, such as during exercise or when fasting.
The Pharmaceutical Research and Manufacturers of America (PhRMA) issued the following statement today on passage of comprehensive health care reform and accompanying reconciliation legislation in the U.S. House of Representatives:
Protein Design Labs, Inc. and privately held Orphan Therapeutics, LLC today reported that the U.S. Food and Drug Administration (FDA) has granted Fast Track status to the development of terlipressin for the treatment of patients with type 1 hepatorenal syndrome (HRS).
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kevin Harm, APRN 4321 41st Ave, Columbus, NE 68601-2131 Ph: (402) 562-7500 | Kevin Harm, APRN 3775 45th Ave, Columbus, NE 68601-4427 Ph: (402) 564-7200 |
News Archive
A study led by Ludwig Chicago Co-director Ralph Weichselbaum and Yang-Xin Fu of the University of Texas Southwestern Medical Center has shown how bacteria in the gut can dull the efficacy of radiotherapy, a treatment received by about half of all cancer patients.
Bernard Arulanandam, UTSA Jane and Roland Blumberg Professor in Biology and Assistant Vice President for Research Support, has been named a fellow of the American Association for the Advancement of Science. Arulanandam was elected by his peers for the honor, recognizing his scientific and socially distinguished efforts to advance science and its applications.
Researchers at McGill University have discovered that a key regulator of energy metabolism in cancer cells known as the AMP-activated protein kinase (AMPK) may play a crucial role in restricting cancer cell growth. AMPK acts as a "fuel gauge" in cells; AMPK is turned on when it senses changes in energy levels, and helps to change metabolism when energy levels are low, such as during exercise or when fasting.
The Pharmaceutical Research and Manufacturers of America (PhRMA) issued the following statement today on passage of comprehensive health care reform and accompanying reconciliation legislation in the U.S. House of Representatives:
Protein Design Labs, Inc. and privately held Orphan Therapeutics, LLC today reported that the U.S. Food and Drug Administration (FDA) has granted Fast Track status to the development of terlipressin for the treatment of patients with type 1 hepatorenal syndrome (HRS).
› Verified 6 days ago
Kay Ritzdorf Wieser, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1454 28th Ave, Columbus, NE 68601 Phone: 402-564-2816 Fax: 402-564-1312 | |
Mrs. Lindsey Mae Bates, APRN-NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4214 38th St, Columbus, NE 68601 Phone: 402-564-1338 Fax: 402-564-8902 | |
Karin Ashley, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 118 23rd St # 189, Columbus, NE 68601 Phone: 402-302-2082 | |
Mrs. Teresa L Stephens, LMHP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 2314 13th St, Columbus, NE 68601 Phone: 402-562-8666 Fax: 402-562-8666 | |
Staci Lyn Stempek, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 4214 38th St, Columbus, NE 68601 Phone: 402-564-1338 Fax: 402-564-8902 | |
Samantha Leigh Mcphillips, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4600 38th St, Columbus, NE 68601 Phone: 402-564-7118 | |
Karla Coria, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 4508 38th St Ste 260, Columbus, NE 68601 Phone: 402-564-0205 Fax: 402-564-2607 |